11-47274982-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001376571.1(MADD):c.482G>A(p.Arg161His) variant causes a missense change. The variant allele was found at a frequency of 0.00134 in 1,614,138 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0065 ( 13 hom., cov: 33)
Exomes 𝑓: 0.00080 ( 8 hom. )
Consequence
MADD
NM_001376571.1 missense
NM_001376571.1 missense
Scores
2
4
12
Clinical Significance
Conservation
PhyloP100: 5.28
Genes affected
MADD (HGNC:6766): (MAP kinase activating death domain) Tumor necrosis factor alpha (TNF-alpha) is a signaling molecule that interacts with one of two receptors on cells targeted for apoptosis. The apoptotic signal is transduced inside these cells by cytoplasmic adaptor proteins. The protein encoded by this gene is a death domain-containing adaptor protein that interacts with the death domain of TNF-alpha receptor 1 to activate mitogen-activated protein kinase (MAPK) and propagate the apoptotic signal. It is membrane-bound and expressed at a higher level in neoplastic cells than in normal cells. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.00607574).
BP6
Variant 11-47274982-G-A is Benign according to our data. Variant chr11-47274982-G-A is described in ClinVar as [Benign]. Clinvar id is 779197.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00649 (989/152336) while in subpopulation AFR AF= 0.0227 (945/41574). AF 95% confidence interval is 0.0215. There are 13 homozygotes in gnomad4. There are 474 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MADD | NM_001376571.1 | c.482G>A | p.Arg161His | missense_variant | 3/37 | NP_001363500.1 | ||
MADD | NM_003682.4 | c.482G>A | p.Arg161His | missense_variant | 3/36 | NP_003673.3 | ||
MADD | NM_001376572.1 | c.482G>A | p.Arg161His | missense_variant | 3/37 | NP_001363501.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MADD | ENST00000706887.1 | c.482G>A | p.Arg161His | missense_variant | 3/37 | ENSP00000516604.1 |
Frequencies
GnomAD3 genomes AF: 0.00649 AC: 988AN: 152218Hom.: 13 Cov.: 33
GnomAD3 genomes
AF:
AC:
988
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00180 AC: 452AN: 251152Hom.: 6 AF XY: 0.00111 AC XY: 151AN XY: 135772
GnomAD3 exomes
AF:
AC:
452
AN:
251152
Hom.:
AF XY:
AC XY:
151
AN XY:
135772
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000800 AC: 1169AN: 1461802Hom.: 8 Cov.: 32 AF XY: 0.000653 AC XY: 475AN XY: 727208
GnomAD4 exome
AF:
AC:
1169
AN:
1461802
Hom.:
Cov.:
32
AF XY:
AC XY:
475
AN XY:
727208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00649 AC: 989AN: 152336Hom.: 13 Cov.: 33 AF XY: 0.00636 AC XY: 474AN XY: 74490
GnomAD4 genome
AF:
AC:
989
AN:
152336
Hom.:
Cov.:
33
AF XY:
AC XY:
474
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
89
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
253
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 27, 2018 | - - |
MADD-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 26, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Pathogenic
DEOGEN2
Benign
T;.;.;.;T;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;N;N;N;N;N;N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D;D;D;D;D;D;D
REVEL
Benign
Sift
Benign
T;T;T;D;D;T;T;D;T
Sift4G
Benign
T;T;T;T;T;T;T;T;T
Polyphen
1.0, 0.90, 0.84, 1.0, 0.99, 0.95
.;D;D;P;P;D;.;D;P
Vest4
MVP
MPC
0.43
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at